Range Low Price High Price Comment
30 days $1.45 $1.68 Friday, 27th Jan 2023 CLSN stock ended at $1.56. This is 4.00% more than the trading day before Thursday, 26th Jan 2023. During the day the stock fluctuated 7.38% from a day low at $1.49 to a day high of $1.60.
90 days $1.45 $1.68
52 weeks $0.370 $7.68

Historical Celsion Corporation prices

Date Open High Low Close Volume
2022-12-20 $1.68 $1.68 $1.68 $1.68 0
2022-12-19 $1.68 $1.68 $1.68 $1.68 0
2022-12-16 $1.68 $1.68 $1.68 $1.68 0
2022-12-15 $1.68 $1.68 $1.68 $1.68 0
2022-12-14 $1.68 $1.68 $1.68 $1.68 0
2022-12-13 $1.68 $1.68 $1.68 $1.68 0
2022-12-12 $1.68 $1.68 $1.68 $1.68 0
2022-12-09 $1.68 $1.68 $1.68 $1.68 0
2022-12-08 $1.68 $1.68 $1.68 $1.68 0
2022-12-07 $1.68 $1.68 $1.68 $1.68 0
2022-12-06 $1.68 $1.68 $1.68 $1.68 0
2022-12-05 $1.68 $1.68 $1.68 $1.68 0
2022-12-02 $1.68 $1.68 $1.68 $1.68 0
2022-12-01 $1.68 $1.68 $1.68 $1.68 0
2022-11-30 $1.68 $1.68 $1.68 $1.68 0
2022-11-29 $1.68 $1.68 $1.68 $1.68 0
2022-11-28 $1.68 $1.68 $1.68 $1.68 0
2022-11-25 $1.68 $1.68 $1.68 $1.68 0
2022-11-23 $1.68 $1.68 $1.68 $1.68 0
2022-11-22 $1.68 $1.68 $1.68 $1.68 0
2022-11-21 $1.68 $1.68 $1.68 $1.68 0
2022-11-18 $1.68 $1.68 $1.68 $1.68 0
2022-11-17 $1.68 $1.68 $1.68 $1.68 0
2022-11-16 $1.68 $1.68 $1.68 $1.68 0
2022-11-15 $1.68 $1.68 $1.68 $1.68 0
Click to get the best stock tips daily for free!

About Celsion Corporation

Celsion Celsion Corporation, a clinical stage biotechnology company, focuses on the development and commercialization of DNA-based immunotherapies, vaccines, and directed chemotherapies. Its product pipeline includes GEN-1, a DNA-based immunotherapy for the localized treatment of ovarian cancer; and ThermoDox, a proprietary heat-activated liposomal encapsulation of doxorubicin, which is in development stage for various cancer indications. The company als... CLSN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT